DERMATA THERAPEUTICS INC
DRMA·249845504·US·Common Stock·Healthcare - Biotechnology-Activist
DRMA (DERMATA THERAPEUTICS INC) is held by 3 institutional investors as of Q1 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($58,483), UBS Group AG ($43,085), CITIGROUP INC ($1). Net institutional sentiment: Mixed.
3
Holders
Avg rating(2 Elite)
$101,569
Total Value
43% (7)
Fund Consensus
3 buying - 4 selling
Who's Trading
ActivistKKKyri K. Van Hoose9.0%Jun 1, 2026
ActivistMPMitchell P. Kopin5.0%May 13, 2026
ActivistBLBIGGER CAPITAL FUND L P1.9%Apr 22, 2026
ActivistPGPROEHL GERALD T17.3%Feb 23, 2026
ActivistARArmistice Capital, LLC5.0%Feb 18, 2026
InsiderBEBedoya-Toro Munera Maria EBuy $1KFeb 17, 2026
ActivistMPMitchell P. Kopin5.5%Jan 2, 2026
ActivistARArmistice Capital, LLC10.0%May 15, 2025
ActivistPGPROEHL GERALD T13.3%Apr 7, 2025
ActivistPGPROEHL GERALD T7.8%Apr 3, 2025
13F: Insider & Congress:
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer